Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 87 | 2022 | 1815 | 6.690 |
Why?
|
Neuromuscular Nondepolarizing Agents | 27 | 2011 | 147 | 3.850 |
Why?
|
Neuromuscular Junction | 31 | 2019 | 398 | 3.330 |
Why?
|
Receptors, Cholinergic | 25 | 2015 | 238 | 3.190 |
Why?
|
Muscle, Skeletal | 46 | 2020 | 4931 | 2.740 |
Why?
|
Muscular Atrophy | 12 | 2020 | 349 | 2.650 |
Why?
|
Benzylidene Compounds | 4 | 2021 | 27 | 2.390 |
Why?
|
Tubocurarine | 26 | 2000 | 63 | 1.590 |
Why?
|
Muscle Contraction | 28 | 2015 | 1240 | 1.460 |
Why?
|
Receptors, Nicotinic | 13 | 2016 | 497 | 1.440 |
Why?
|
Immobilization | 10 | 2014 | 236 | 1.310 |
Why?
|
Drug Tolerance | 5 | 2019 | 376 | 1.290 |
Why?
|
Neuromuscular Depolarizing Agents | 6 | 2009 | 45 | 1.150 |
Why?
|
Morphine | 4 | 2022 | 657 | 1.150 |
Why?
|
Rats, Sprague-Dawley | 42 | 2022 | 8301 | 1.130 |
Why?
|
Muscles | 19 | 2017 | 1614 | 1.120 |
Why?
|
Synaptic Transmission | 8 | 2014 | 1178 | 1.120 |
Why?
|
Isoquinolines | 7 | 2011 | 367 | 1.080 |
Why?
|
Pyridines | 4 | 2021 | 2825 | 1.030 |
Why?
|
Androstanols | 5 | 2009 | 47 | 1.000 |
Why?
|
Succinylcholine | 8 | 2013 | 67 | 0.940 |
Why?
|
Neuromuscular Blockade | 6 | 2009 | 146 | 0.930 |
Why?
|
Apoptosis | 13 | 2019 | 9727 | 0.890 |
Why?
|
Electric Stimulation | 11 | 2015 | 1767 | 0.890 |
Why?
|
Critical Illness | 7 | 2019 | 2670 | 0.880 |
Why?
|
Carbamazepine | 3 | 2019 | 229 | 0.850 |
Why?
|
Analgesics, Opioid | 6 | 2019 | 3674 | 0.800 |
Why?
|
Mitochondria | 10 | 2023 | 3520 | 0.790 |
Why?
|
Fentanyl | 2 | 2019 | 410 | 0.790 |
Why?
|
Rats | 49 | 2022 | 24260 | 0.770 |
Why?
|
Neuromuscular Blocking Agents | 7 | 2013 | 130 | 0.770 |
Why?
|
Botulinum Toxins | 3 | 2013 | 191 | 0.710 |
Why?
|
Spinal Cord | 4 | 2022 | 1809 | 0.700 |
Why?
|
Muscle Weakness | 8 | 2016 | 413 | 0.690 |
Why?
|
Cholinesterase Inhibitors | 4 | 2013 | 238 | 0.680 |
Why?
|
Nitric Oxide Synthase Type II | 7 | 2017 | 534 | 0.680 |
Why?
|
Hyperalgesia | 4 | 2022 | 502 | 0.680 |
Why?
|
Myoblasts, Skeletal | 2 | 2017 | 76 | 0.650 |
Why?
|
Muscle Fibers, Skeletal | 4 | 2017 | 555 | 0.640 |
Why?
|
Anticonvulsants | 4 | 2019 | 1916 | 0.640 |
Why?
|
Insulin Resistance | 12 | 2015 | 3864 | 0.630 |
Why?
|
Midazolam | 4 | 2016 | 270 | 0.620 |
Why?
|
Anesthetics, Intravenous | 2 | 2012 | 417 | 0.610 |
Why?
|
Refractory Period, Electrophysiological | 2 | 2016 | 39 | 0.600 |
Why?
|
Muscle Proteins | 4 | 2017 | 1159 | 0.590 |
Why?
|
Muscular Disorders, Atrophic | 2 | 2015 | 33 | 0.570 |
Why?
|
Pain Measurement | 5 | 2021 | 3420 | 0.570 |
Why?
|
Pyridostigmine Bromide | 2 | 2013 | 31 | 0.560 |
Why?
|
Heat-Shock Proteins | 1 | 2020 | 822 | 0.560 |
Why?
|
Lipopolysaccharides | 4 | 2019 | 2216 | 0.540 |
Why?
|
Motor Neurons | 2 | 2019 | 844 | 0.540 |
Why?
|
Animals | 99 | 2022 | 168757 | 0.530 |
Why?
|
Nicotinic Agonists | 2 | 2021 | 271 | 0.530 |
Why?
|
Muscular Dystrophy, Animal | 2 | 2013 | 90 | 0.520 |
Why?
|
Bungarotoxins | 6 | 2015 | 46 | 0.500 |
Why?
|
Propofol | 2 | 2012 | 629 | 0.500 |
Why?
|
Microglia | 2 | 2022 | 1266 | 0.500 |
Why?
|
Anesthesia, Intravenous | 3 | 2012 | 130 | 0.480 |
Why?
|
Neuromuscular Diseases | 3 | 2013 | 248 | 0.470 |
Why?
|
Pain | 5 | 2022 | 4986 | 0.470 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2014 | 143 | 0.460 |
Why?
|
Pancuronium | 7 | 2004 | 45 | 0.460 |
Why?
|
Toxins, Biological | 1 | 2013 | 66 | 0.440 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2012 | 430 | 0.420 |
Why?
|
Up-Regulation | 12 | 2016 | 4217 | 0.420 |
Why?
|
Lipolysis | 2 | 2006 | 210 | 0.410 |
Why?
|
Hyperkalemia | 3 | 2006 | 218 | 0.410 |
Why?
|
Caspase 3 | 2 | 2013 | 758 | 0.410 |
Why?
|
Atracurium | 7 | 2011 | 52 | 0.410 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1889 | 0.410 |
Why?
|
Inflammation | 7 | 2019 | 10638 | 0.400 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 365 | 0.390 |
Why?
|
Dose-Response Relationship, Drug | 22 | 2019 | 10943 | 0.380 |
Why?
|
Acetylcholinesterase | 4 | 2009 | 153 | 0.380 |
Why?
|
Vecuronium Bromide | 3 | 2001 | 33 | 0.380 |
Why?
|
Hypnotics and Sedatives | 4 | 2015 | 1162 | 0.370 |
Why?
|
Insulin | 10 | 2019 | 6580 | 0.360 |
Why?
|
Sepsis | 3 | 2021 | 2593 | 0.360 |
Why?
|
Lysine | 2 | 2012 | 1007 | 0.350 |
Why?
|
Mice, Inbred C57BL | 16 | 2019 | 21827 | 0.340 |
Why?
|
Male | 99 | 2021 | 350118 | 0.340 |
Why?
|
Intubation, Intratracheal | 3 | 2013 | 1364 | 0.330 |
Why?
|
Phenytoin | 3 | 2001 | 197 | 0.330 |
Why?
|
Dexmedetomidine | 1 | 2013 | 315 | 0.330 |
Why?
|
Hyperglycemia | 3 | 2008 | 1373 | 0.320 |
Why?
|
Drug Interactions | 9 | 2019 | 1460 | 0.320 |
Why?
|
Monitoring, Intraoperative | 2 | 2013 | 957 | 0.320 |
Why?
|
Autophagy | 3 | 2015 | 1300 | 0.310 |
Why?
|
Down-Regulation | 3 | 2013 | 3002 | 0.300 |
Why?
|
Interleukin-6 | 1 | 2017 | 3200 | 0.300 |
Why?
|
Myocardium | 5 | 2012 | 4776 | 0.300 |
Why?
|
Perioperative Care | 1 | 2015 | 1002 | 0.300 |
Why?
|
Half-Life | 5 | 2019 | 661 | 0.290 |
Why?
|
Receptors, Adrenergic, beta | 2 | 1999 | 246 | 0.290 |
Why?
|
Nitric Oxide Synthase | 4 | 2005 | 916 | 0.280 |
Why?
|
Piperidines | 1 | 2014 | 1602 | 0.280 |
Why?
|
Disease Models, Animal | 11 | 2019 | 18029 | 0.280 |
Why?
|
Oligopeptides | 1 | 2011 | 1189 | 0.270 |
Why?
|
Necrosis | 2 | 2007 | 1643 | 0.260 |
Why?
|
Contracture | 1 | 2008 | 223 | 0.260 |
Why?
|
Mice | 33 | 2019 | 81183 | 0.260 |
Why?
|
Anesthesia | 8 | 2016 | 1561 | 0.260 |
Why?
|
Acetophenones | 2 | 2016 | 48 | 0.250 |
Why?
|
Conotoxins | 2 | 2015 | 20 | 0.250 |
Why?
|
Dihydro-beta-Erythroidine | 2 | 2015 | 4 | 0.250 |
Why?
|
Cyclic AMP | 10 | 1999 | 1472 | 0.250 |
Why?
|
Pyrazoles | 1 | 2014 | 1972 | 0.240 |
Why?
|
Butyrylcholinesterase | 2 | 2011 | 22 | 0.240 |
Why?
|
Hemodynamics | 5 | 2013 | 4199 | 0.240 |
Why?
|
Cholinesterases | 2 | 2002 | 34 | 0.240 |
Why?
|
Exercise | 1 | 2020 | 5615 | 0.240 |
Why?
|
Muscular Diseases | 4 | 2009 | 556 | 0.230 |
Why?
|
Antioxidants | 1 | 2011 | 1663 | 0.230 |
Why?
|
Enzyme Inhibitors | 3 | 2012 | 3798 | 0.230 |
Why?
|
Neck | 1 | 2008 | 697 | 0.230 |
Why?
|
Glucocorticoids | 2 | 2004 | 2107 | 0.220 |
Why?
|
Airway Obstruction | 1 | 2008 | 664 | 0.220 |
Why?
|
Cholinergic Agonists | 1 | 2022 | 74 | 0.220 |
Why?
|
Liver | 5 | 2012 | 7474 | 0.220 |
Why?
|
Cimetidine | 3 | 1989 | 78 | 0.210 |
Why?
|
Receptors, Glucocorticoid | 1 | 2004 | 302 | 0.210 |
Why?
|
Muscle Relaxation | 3 | 2009 | 142 | 0.210 |
Why?
|
Adipocytes | 3 | 2006 | 1184 | 0.200 |
Why?
|
Sodium Chloride | 2 | 2015 | 625 | 0.200 |
Why?
|
Acetylcholine | 4 | 2013 | 621 | 0.200 |
Why?
|
Endoplasmic Reticulum | 1 | 2007 | 1144 | 0.200 |
Why?
|
Random Allocation | 5 | 2016 | 2429 | 0.190 |
Why?
|
Receptor, Insulin | 5 | 2011 | 846 | 0.190 |
Why?
|
Lipid Metabolism | 2 | 2006 | 1889 | 0.190 |
Why?
|
Protein Prenylation | 2 | 2017 | 73 | 0.180 |
Why?
|
In Situ Nick-End Labeling | 5 | 2006 | 643 | 0.180 |
Why?
|
Caspases | 2 | 2000 | 928 | 0.180 |
Why?
|
Phosphodiesterase 5 Inhibitors | 2 | 2013 | 101 | 0.170 |
Why?
|
Immunoblotting | 3 | 2017 | 1682 | 0.170 |
Why?
|
Diaphragm | 5 | 1996 | 349 | 0.170 |
Why?
|
Phosphoproteins | 5 | 2005 | 2440 | 0.170 |
Why?
|
Prednisolone | 1 | 2000 | 334 | 0.170 |
Why?
|
Toll-Like Receptor 4 | 1 | 2022 | 565 | 0.170 |
Why?
|
Nucleotides, Cyclic | 2 | 1990 | 81 | 0.170 |
Why?
|
Glucose | 5 | 2012 | 4397 | 0.160 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2016 | 297 | 0.160 |
Why?
|
Second Messenger Systems | 2 | 1996 | 206 | 0.160 |
Why?
|
Enzyme Activation | 5 | 2017 | 3701 | 0.160 |
Why?
|
Humans | 83 | 2023 | 744343 | 0.160 |
Why?
|
Neurons | 3 | 2019 | 9338 | 0.160 |
Why?
|
Signal Transduction | 11 | 2019 | 23403 | 0.150 |
Why?
|
Macrophages | 1 | 2012 | 5655 | 0.150 |
Why?
|
Muscle Denervation | 1 | 1997 | 57 | 0.150 |
Why?
|
Ubiquinone | 1 | 2019 | 188 | 0.150 |
Why?
|
Drug Administration Schedule | 4 | 2013 | 4933 | 0.150 |
Why?
|
Muscle Fatigue | 2 | 2011 | 83 | 0.150 |
Why?
|
Pseudomonas aeruginosa | 2 | 2016 | 1219 | 0.150 |
Why?
|
Muscle Relaxants, Central | 3 | 1992 | 86 | 0.150 |
Why?
|
Neutrophil Infiltration | 1 | 2019 | 390 | 0.150 |
Why?
|
Glycyrrhizic Acid | 1 | 2016 | 11 | 0.150 |
Why?
|
Chromatography, Liquid | 2 | 2019 | 976 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4420 | 0.140 |
Why?
|
Hindlimb Suspension | 1 | 2016 | 83 | 0.140 |
Why?
|
Hindlimb | 6 | 2010 | 504 | 0.140 |
Why?
|
Phosphorylation | 7 | 2012 | 8436 | 0.140 |
Why?
|
Neostigmine | 1 | 1996 | 69 | 0.140 |
Why?
|
Microcirculation | 2 | 2013 | 1286 | 0.130 |
Why?
|
Transcription Factor RelA | 1 | 2017 | 275 | 0.130 |
Why?
|
Sirtuin 1 | 1 | 2017 | 246 | 0.130 |
Why?
|
Sarcopenia | 1 | 2020 | 368 | 0.130 |
Why?
|
Insulin Receptor Substrate Proteins | 6 | 2011 | 563 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 4554 | 0.130 |
Why?
|
Burns, Inhalation | 1 | 2015 | 33 | 0.130 |
Why?
|
Sodium Channels | 1 | 1997 | 349 | 0.130 |
Why?
|
Time Factors | 16 | 2013 | 40075 | 0.130 |
Why?
|
Pain Threshold | 1 | 2019 | 584 | 0.130 |
Why?
|
RNA, Messenger | 8 | 2002 | 13033 | 0.130 |
Why?
|
Burns, Electric | 1 | 2015 | 42 | 0.130 |
Why?
|
Cyclic GMP | 3 | 1990 | 409 | 0.120 |
Why?
|
Nicotinic Antagonists | 2 | 2011 | 96 | 0.120 |
Why?
|
Tissue Distribution | 1 | 2019 | 2327 | 0.120 |
Why?
|
Area Under Curve | 1 | 2019 | 1654 | 0.120 |
Why?
|
Orosomucoid | 5 | 2005 | 45 | 0.120 |
Why?
|
Myography | 2 | 2014 | 109 | 0.120 |
Why?
|
Cardiac Volume | 3 | 1986 | 210 | 0.120 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 1992 | 1572 | 0.120 |
Why?
|
Crotalid Venoms | 1 | 2014 | 28 | 0.120 |
Why?
|
Injections, Spinal | 1 | 2014 | 303 | 0.120 |
Why?
|
Adipose Tissue | 1 | 2006 | 3279 | 0.120 |
Why?
|
Hyperkinesis | 1 | 2014 | 89 | 0.120 |
Why?
|
Atrophy | 2 | 2014 | 1583 | 0.120 |
Why?
|
Models, Animal | 1 | 2020 | 2171 | 0.120 |
Why?
|
NF-kappa B | 1 | 2022 | 2499 | 0.120 |
Why?
|
Cardiac Output | 7 | 1986 | 854 | 0.120 |
Why?
|
Muscle Fibers, Slow-Twitch | 1 | 2013 | 49 | 0.120 |
Why?
|
Muscle Fibers, Fast-Twitch | 1 | 2013 | 69 | 0.110 |
Why?
|
Carbolines | 2 | 2013 | 265 | 0.110 |
Why?
|
Binding, Competitive | 3 | 2009 | 1157 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 627 | 0.110 |
Why?
|
Mass Spectrometry | 2 | 2019 | 2203 | 0.110 |
Why?
|
Neuromuscular Agents | 1 | 1995 | 134 | 0.110 |
Why?
|
Metabolic Clearance Rate | 3 | 2007 | 380 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.110 |
Why?
|
Fibrinogen | 1 | 2016 | 894 | 0.110 |
Why?
|
Physical Stimulation | 1 | 2014 | 525 | 0.110 |
Why?
|
Body Weight | 8 | 2000 | 4669 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2017 | 484 | 0.110 |
Why?
|
Glycogen Synthase | 1 | 2012 | 62 | 0.110 |
Why?
|
Drug Combinations | 2 | 2016 | 1959 | 0.110 |
Why?
|
Drug Resistance | 7 | 2005 | 1609 | 0.110 |
Why?
|
Diazepam | 2 | 1984 | 205 | 0.110 |
Why?
|
Mice, Knockout | 4 | 2017 | 14557 | 0.110 |
Why?
|
Multiple Organ Failure | 2 | 2007 | 390 | 0.110 |
Why?
|
Anesthetics | 3 | 2016 | 539 | 0.110 |
Why?
|
Anesthesia, General | 5 | 2004 | 1171 | 0.110 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1097 | 0.110 |
Why?
|
Ranitidine | 1 | 1992 | 34 | 0.110 |
Why?
|
Glucose Clamp Technique | 1 | 2012 | 266 | 0.110 |
Why?
|
Nitriles | 1 | 2017 | 956 | 0.100 |
Why?
|
Analysis of Variance | 3 | 2012 | 6365 | 0.100 |
Why?
|
Organ Size | 3 | 2001 | 2252 | 0.100 |
Why?
|
Blotting, Western | 3 | 2014 | 5179 | 0.100 |
Why?
|
Reactive Oxygen Species | 3 | 2016 | 2077 | 0.100 |
Why?
|
Anesthesia Recovery Period | 2 | 2004 | 157 | 0.100 |
Why?
|
Intensive Care Units | 2 | 2019 | 3679 | 0.100 |
Why?
|
Triazoles | 1 | 2017 | 911 | 0.100 |
Why?
|
Peptides, Cyclic | 1 | 2014 | 400 | 0.100 |
Why?
|
Pseudomonas Infections | 1 | 2016 | 613 | 0.100 |
Why?
|
Toxemia | 1 | 1990 | 14 | 0.100 |
Why?
|
Transcription, Genetic | 2 | 2004 | 7722 | 0.090 |
Why?
|
Aging | 5 | 2014 | 8664 | 0.090 |
Why?
|
Endotoxins | 2 | 1990 | 527 | 0.090 |
Why?
|
Injections, Intramuscular | 1 | 2011 | 552 | 0.090 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 617 | 0.090 |
Why?
|
Mitochondrial Diseases | 1 | 2013 | 320 | 0.090 |
Why?
|
Isaacs Syndrome | 1 | 2009 | 6 | 0.090 |
Why?
|
Neuromuscular Junction Diseases | 1 | 2009 | 14 | 0.090 |
Why?
|
Adolescent | 20 | 2016 | 85781 | 0.090 |
Why?
|
Female | 33 | 2019 | 380194 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2011 | 2938 | 0.090 |
Why?
|
Neuroglia | 1 | 2014 | 927 | 0.080 |
Why?
|
Synaptic Potentials | 1 | 2009 | 43 | 0.080 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2187 | 0.080 |
Why?
|
Adult | 28 | 2019 | 214055 | 0.080 |
Why?
|
Muscle Strength | 2 | 2010 | 592 | 0.080 |
Why?
|
Child, Preschool | 12 | 2013 | 41006 | 0.080 |
Why?
|
Hypoglycemic Agents | 1 | 2000 | 2872 | 0.080 |
Why?
|
Protein-Energy Malnutrition | 1 | 1989 | 187 | 0.080 |
Why?
|
Antacids | 2 | 1986 | 99 | 0.080 |
Why?
|
Child | 22 | 2016 | 77709 | 0.080 |
Why?
|
Nitric Oxide Donors | 2 | 2005 | 121 | 0.080 |
Why?
|
Middle Aged | 24 | 2019 | 213383 | 0.080 |
Why?
|
Pneumonia | 1 | 2019 | 2133 | 0.080 |
Why?
|
Infant | 9 | 2013 | 35136 | 0.080 |
Why?
|
Synaptic Vesicles | 1 | 2009 | 191 | 0.080 |
Why?
|
MyoD Protein | 2 | 2001 | 151 | 0.080 |
Why?
|
Pulmonary Wedge Pressure | 2 | 1986 | 264 | 0.070 |
Why?
|
Lorazepam | 1 | 1988 | 145 | 0.070 |
Why?
|
Rats, Inbred Strains | 4 | 1992 | 2186 | 0.070 |
Why?
|
Cell Line | 3 | 2017 | 15997 | 0.070 |
Why?
|
Denervation | 2 | 2015 | 278 | 0.070 |
Why?
|
Infusions, Intravenous | 2 | 2004 | 2274 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1477 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3719 | 0.070 |
Why?
|
Palliative Care | 1 | 2002 | 3493 | 0.070 |
Why?
|
Kinetics | 5 | 1999 | 6473 | 0.070 |
Why?
|
Gastric Mucosa | 2 | 1992 | 599 | 0.070 |
Why?
|
Potassium | 3 | 1987 | 1336 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2948 | 0.070 |
Why?
|
Oxidative Stress | 2 | 2016 | 3086 | 0.070 |
Why?
|
Ulnar Nerve | 3 | 2000 | 106 | 0.070 |
Why?
|
Adrenergic beta-Agonists | 2 | 1999 | 346 | 0.070 |
Why?
|
Obesity | 1 | 2008 | 12745 | 0.070 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2008 | 612 | 0.070 |
Why?
|
Prospective Studies | 8 | 2017 | 53288 | 0.070 |
Why?
|
Hypothermia | 1 | 1987 | 189 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5853 | 0.070 |
Why?
|
Anti-Anxiety Agents | 3 | 2002 | 390 | 0.070 |
Why?
|
Cells, Cultured | 4 | 2012 | 19229 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2011 | 21746 | 0.070 |
Why?
|
Cardiac Output, Low | 1 | 1986 | 195 | 0.060 |
Why?
|
Electromyography | 2 | 2001 | 1379 | 0.060 |
Why?
|
Penicillamine | 1 | 2005 | 59 | 0.060 |
Why?
|
Protein Subunits | 2 | 2006 | 959 | 0.060 |
Why?
|
Thorax | 1 | 2008 | 547 | 0.060 |
Why?
|
Tyrosine | 3 | 2011 | 1461 | 0.060 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 104 | 0.060 |
Why?
|
Stroke Volume | 6 | 1986 | 5007 | 0.060 |
Why?
|
Critical Care | 3 | 2013 | 2647 | 0.060 |
Why?
|
Adrenergic beta-Antagonists | 2 | 1987 | 1240 | 0.060 |
Why?
|
Nitric Oxide | 4 | 2007 | 2132 | 0.060 |
Why?
|
Epididymis | 1 | 2006 | 227 | 0.060 |
Why?
|
Imipramine | 1 | 1984 | 97 | 0.060 |
Why?
|
Thermodilution | 2 | 1981 | 52 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7322 | 0.060 |
Why?
|
Serine | 2 | 2005 | 826 | 0.060 |
Why?
|
Threonine | 1 | 2004 | 279 | 0.060 |
Why?
|
Muscle Cells | 1 | 2005 | 197 | 0.060 |
Why?
|
Escherichia coli | 2 | 2007 | 4217 | 0.060 |
Why?
|
Blood Glucose | 2 | 2011 | 6256 | 0.060 |
Why?
|
Myasthenia Gravis | 2 | 1999 | 199 | 0.060 |
Why?
|
Hydrogen Peroxide | 2 | 2023 | 731 | 0.060 |
Why?
|
Blotting, Northern | 2 | 1997 | 1581 | 0.060 |
Why?
|
Comet Assay | 1 | 2003 | 71 | 0.060 |
Why?
|
Escherichia coli Infections | 1 | 2007 | 532 | 0.060 |
Why?
|
Fasting | 3 | 2005 | 1593 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 480 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2011 | 2503 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3505 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 489 | 0.050 |
Why?
|
Cattle | 2 | 2001 | 3922 | 0.050 |
Why?
|
Glycogen Phosphorylase | 1 | 2002 | 16 | 0.050 |
Why?
|
Microscopy, Electron | 2 | 2003 | 2645 | 0.050 |
Why?
|
Aged | 14 | 2019 | 163280 | 0.050 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2002 | 38 | 0.050 |
Why?
|
Benzodiazepines | 3 | 2002 | 1101 | 0.050 |
Why?
|
Microscopy | 1 | 2007 | 903 | 0.050 |
Why?
|
Injections, Intravenous | 2 | 2000 | 1420 | 0.050 |
Why?
|
Agrin | 1 | 2001 | 68 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2003 | 743 | 0.050 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2002 | 109 | 0.050 |
Why?
|
Anesthetics, Dissociative | 1 | 2002 | 80 | 0.050 |
Why?
|
Isometric Contraction | 1 | 2001 | 143 | 0.050 |
Why?
|
Enzyme Induction | 1 | 2002 | 475 | 0.050 |
Why?
|
Action Potentials | 1 | 2009 | 1806 | 0.050 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2023 | 402 | 0.050 |
Why?
|
Thoracic Surgery | 1 | 2008 | 719 | 0.050 |
Why?
|
Guanidines | 1 | 2002 | 193 | 0.050 |
Why?
|
Thumb | 2 | 2000 | 227 | 0.050 |
Why?
|
Ventilator Weaning | 1 | 2002 | 148 | 0.050 |
Why?
|
Ketamine | 1 | 1987 | 500 | 0.050 |
Why?
|
Cytochrome c Group | 1 | 2000 | 128 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3870 | 0.050 |
Why?
|
Phosphotyrosine | 2 | 2001 | 457 | 0.050 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2004 | 436 | 0.050 |
Why?
|
Tissue Expansion | 1 | 2002 | 162 | 0.050 |
Why?
|
Food Deprivation | 1 | 2000 | 116 | 0.050 |
Why?
|
Respiratory Insufficiency | 2 | 2008 | 1199 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4838 | 0.050 |
Why?
|
Wasting Syndrome | 1 | 2000 | 101 | 0.040 |
Why?
|
Abdominal Muscles | 1 | 2000 | 166 | 0.040 |
Why?
|
Hypocalcemia | 1 | 1981 | 191 | 0.040 |
Why?
|
Hepatocytes | 2 | 2023 | 1211 | 0.040 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2003 | 476 | 0.040 |
Why?
|
Sterol Esterase | 1 | 1999 | 37 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 3 | 1992 | 2557 | 0.040 |
Why?
|
Length of Stay | 1 | 2013 | 6309 | 0.040 |
Why?
|
Reference Values | 3 | 2001 | 4982 | 0.040 |
Why?
|
Ethanolamines | 1 | 1999 | 158 | 0.040 |
Why?
|
Lidocaine | 1 | 2002 | 544 | 0.040 |
Why?
|
Steroids | 1 | 2004 | 930 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9239 | 0.040 |
Why?
|
Heart Ventricles | 5 | 1996 | 3821 | 0.040 |
Why?
|
Dopamine | 1 | 1986 | 1591 | 0.040 |
Why?
|
Drug Synergism | 3 | 1997 | 1792 | 0.040 |
Why?
|
Ceramides | 1 | 1999 | 199 | 0.040 |
Why?
|
Ischemia | 1 | 2007 | 1907 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2006 | 1547 | 0.040 |
Why?
|
Blood Proteins | 3 | 1992 | 1124 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2023 | 1185 | 0.040 |
Why?
|
Histocytochemistry | 1 | 1999 | 719 | 0.040 |
Why?
|
Pharmaceutical Preparations | 1 | 1986 | 1071 | 0.040 |
Why?
|
Phrenic Nerve | 2 | 1996 | 79 | 0.040 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2017 | 38 | 0.040 |
Why?
|
DNA, Satellite | 1 | 1997 | 69 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2008 | 1622 | 0.040 |
Why?
|
Membrane Potentials | 1 | 2000 | 1137 | 0.040 |
Why?
|
Fluid Therapy | 1 | 1981 | 593 | 0.040 |
Why?
|
Glucose Transporter Type 4 | 1 | 1997 | 250 | 0.040 |
Why?
|
Microtubules | 1 | 2023 | 1090 | 0.040 |
Why?
|
Saxitoxin | 1 | 1997 | 65 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 491 | 0.040 |
Why?
|
Receptor, IGF Type 2 | 1 | 1996 | 35 | 0.040 |
Why?
|
Evoked Potentials, Motor | 1 | 2000 | 454 | 0.040 |
Why?
|
Wound Healing | 2 | 2013 | 2785 | 0.040 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 1997 | 287 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2012 | 10481 | 0.040 |
Why?
|
Iodocyanopindolol | 1 | 1996 | 9 | 0.040 |
Why?
|
Pindolol | 1 | 1996 | 32 | 0.030 |
Why?
|
Regional Blood Flow | 2 | 2013 | 1525 | 0.030 |
Why?
|
Sheep | 2 | 1996 | 1437 | 0.030 |
Why?
|
Centromere | 1 | 1997 | 220 | 0.030 |
Why?
|
Monosaccharide Transport Proteins | 1 | 1997 | 440 | 0.030 |
Why?
|
Capillary Permeability | 1 | 1979 | 798 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 408 | 0.030 |
Why?
|
Isoproterenol | 1 | 1996 | 399 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 553 | 0.030 |
Why?
|
Gastric Acidity Determination | 2 | 1985 | 62 | 0.030 |
Why?
|
Actins | 1 | 2023 | 2121 | 0.030 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 437 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2002 | 985 | 0.030 |
Why?
|
Farnesyltranstransferase | 1 | 2015 | 76 | 0.030 |
Why?
|
Drug Evaluation | 2 | 1988 | 647 | 0.030 |
Why?
|
Gene Expression | 2 | 2001 | 7799 | 0.030 |
Why?
|
Models, Biological | 3 | 2007 | 9583 | 0.030 |
Why?
|
Pentobarbital | 1 | 2015 | 155 | 0.030 |
Why?
|
Hydrolysis | 1 | 1996 | 682 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2007 | 2400 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 1980 | 1585 | 0.030 |
Why?
|
Neural Conduction | 1 | 1996 | 440 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 1997 | 865 | 0.030 |
Why?
|
Myogenin | 1 | 1993 | 58 | 0.030 |
Why?
|
Tetrazolium Salts | 1 | 2013 | 96 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1085 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 2005 | 1827 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1660 | 0.030 |
Why?
|
Respiration, Artificial | 2 | 2002 | 2569 | 0.030 |
Why?
|
Receptor, IGF Type 1 | 1 | 1996 | 390 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2001 | 2007 | 0.030 |
Why?
|
DNA | 2 | 2013 | 7301 | 0.030 |
Why?
|
Gene Deletion | 1 | 2001 | 2751 | 0.030 |
Why?
|
Mice, Transgenic | 3 | 2015 | 9734 | 0.030 |
Why?
|
Thiopental | 2 | 1983 | 59 | 0.030 |
Why?
|
Radioligand Assay | 1 | 1993 | 374 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 783 | 0.030 |
Why?
|
Survival | 1 | 2013 | 163 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2003 | 5974 | 0.030 |
Why?
|
Quorum Sensing | 1 | 2013 | 131 | 0.030 |
Why?
|
Protein Kinases | 1 | 1999 | 1640 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1996 | 794 | 0.030 |
Why?
|
Methionine | 1 | 2015 | 590 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2017 | 970 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 2282 | 0.030 |
Why?
|
Protein Binding | 5 | 2001 | 9386 | 0.030 |
Why?
|
Depression, Chemical | 2 | 2002 | 191 | 0.030 |
Why?
|
Paralysis | 1 | 1993 | 247 | 0.020 |
Why?
|
Infusion Pumps, Implantable | 1 | 1992 | 156 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2017 | 11366 | 0.020 |
Why?
|
Body Surface Area | 1 | 1991 | 198 | 0.020 |
Why?
|
Respiration | 2 | 1993 | 1653 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2003 | 1912 | 0.020 |
Why?
|
Skin Transplantation | 1 | 2016 | 1074 | 0.020 |
Why?
|
Glucuronates | 1 | 1990 | 40 | 0.020 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 1996 | 1121 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2013 | 767 | 0.020 |
Why?
|
Infusions, Subcutaneous | 1 | 2010 | 42 | 0.020 |
Why?
|
Peritoneal Dialysis | 1 | 1991 | 146 | 0.020 |
Why?
|
Glucuronic Acid | 1 | 1990 | 148 | 0.020 |
Why?
|
Animals, Newborn | 1 | 1996 | 2726 | 0.020 |
Why?
|
Deuterium | 1 | 1990 | 101 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2003 | 1972 | 0.020 |
Why?
|
Muscle Strength Dynamometer | 1 | 2009 | 43 | 0.020 |
Why?
|
Membranes | 2 | 2003 | 173 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2002 | 2838 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 1996 | 1783 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 1086 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2013 | 3760 | 0.020 |
Why?
|
Blood Pressure | 6 | 1986 | 8554 | 0.020 |
Why?
|
Nerve Block | 1 | 2016 | 644 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1999 | 6171 | 0.020 |
Why?
|
Eating | 1 | 1996 | 1536 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2014 | 1227 | 0.020 |
Why?
|
Cell Membrane | 2 | 1996 | 3748 | 0.020 |
Why?
|
Infusion Pumps | 1 | 2010 | 163 | 0.020 |
Why?
|
Awards and Prizes | 1 | 1993 | 375 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2013 | 1547 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 1989 | 425 | 0.020 |
Why?
|
Gastric Acid | 1 | 1989 | 104 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1524 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 895 | 0.020 |
Why?
|
Syndrome | 1 | 1995 | 3251 | 0.020 |
Why?
|
Linear Models | 1 | 1999 | 5952 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2002 | 3057 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1150 | 0.020 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 12072 | 0.020 |
Why?
|
Biotransformation | 1 | 1988 | 168 | 0.020 |
Why?
|
Calcium | 1 | 1981 | 5756 | 0.020 |
Why?
|
Oxygen | 1 | 1979 | 4189 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1996 | 2015 | 0.020 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2007 | 34 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1997 | 6622 | 0.020 |
Why?
|
Sciatic Nerve | 1 | 1991 | 607 | 0.020 |
Why?
|
Young Adult | 2 | 2016 | 56430 | 0.020 |
Why?
|
Theophylline | 1 | 1987 | 132 | 0.020 |
Why?
|
Survival Rate | 1 | 2001 | 12788 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 2025 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1970 | 0.020 |
Why?
|
Pulmonary Circulation | 2 | 1980 | 739 | 0.020 |
Why?
|
RNA | 1 | 1997 | 2749 | 0.020 |
Why?
|
Dinoprostone | 1 | 1989 | 600 | 0.020 |
Why?
|
Azathioprine | 1 | 1988 | 353 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 1993 | 1312 | 0.020 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 215 | 0.020 |
Why?
|
Adrenergic Agonists | 1 | 1986 | 58 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2007 | 262 | 0.020 |
Why?
|
Heart Atria | 2 | 1990 | 1357 | 0.020 |
Why?
|
Thiazoles | 1 | 2013 | 1483 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1643 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 1986 | 419 | 0.020 |
Why?
|
Propionibacterium acnes | 1 | 2005 | 66 | 0.020 |
Why?
|
Analgesics | 2 | 1997 | 1040 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2017 | 57776 | 0.020 |
Why?
|
Dogs | 2 | 1987 | 3912 | 0.020 |
Why?
|
Guaiac | 1 | 1985 | 12 | 0.020 |
Why?
|
Autoradiography | 2 | 1996 | 745 | 0.020 |
Why?
|
Evoked Potentials | 1 | 1991 | 1056 | 0.020 |
Why?
|
Hot Temperature | 1 | 1991 | 1354 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 1990 | 1060 | 0.020 |
Why?
|
Metabolomics | 1 | 2013 | 1484 | 0.020 |
Why?
|
Tachycardia | 1 | 1987 | 619 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2001 | 7880 | 0.020 |
Why?
|
Mice, Obese | 1 | 2005 | 424 | 0.020 |
Why?
|
Epilepsy | 1 | 2000 | 3310 | 0.010 |
Why?
|
Connective Tissue | 2 | 1996 | 420 | 0.010 |
Why?
|
Vascular Resistance | 3 | 1983 | 936 | 0.010 |
Why?
|
Nordazepam | 1 | 1983 | 5 | 0.010 |
Why?
|
Nitrogen | 1 | 2005 | 344 | 0.010 |
Why?
|
Diastole | 1 | 1986 | 791 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 1423 | 0.010 |
Why?
|
Creatinine | 1 | 1989 | 1919 | 0.010 |
Why?
|
3T3 Cells | 1 | 2005 | 1101 | 0.010 |
Why?
|
Anxiety | 1 | 1997 | 4297 | 0.010 |
Why?
|
Ultrasonography | 1 | 2016 | 5985 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2007 | 514 | 0.010 |
Why?
|
COS Cells | 1 | 2005 | 1161 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5172 | 0.010 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 625 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2009 | 1827 | 0.010 |
Why?
|
Calcium Metabolism Disorders | 1 | 1981 | 11 | 0.010 |
Why?
|
Societies, Medical | 1 | 1993 | 3743 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2005 | 2050 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 11725 | 0.010 |
Why?
|
Serum Albumin | 1 | 1984 | 676 | 0.010 |
Why?
|
Lung | 1 | 1979 | 9856 | 0.010 |
Why?
|
Bacteremia | 1 | 2007 | 962 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2001 | 438 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2000 | 242 | 0.010 |
Why?
|
Age Factors | 1 | 1997 | 18370 | 0.010 |
Why?
|
Myostatin | 1 | 2001 | 124 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 1997 | 7279 | 0.010 |
Why?
|
Cysteine | 1 | 2005 | 874 | 0.010 |
Why?
|
Phosphorus | 1 | 1981 | 338 | 0.010 |
Why?
|
Heart Rate | 3 | 1986 | 4091 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2005 | 2187 | 0.010 |
Why?
|
Partial Pressure | 1 | 1979 | 254 | 0.010 |
Why?
|
Ubiquitin | 1 | 2005 | 852 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9648 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1917 | 0.010 |
Why?
|
Body Water | 1 | 1980 | 343 | 0.010 |
Why?
|
Rabbits | 2 | 2000 | 4894 | 0.010 |
Why?
|
Vasopressins | 1 | 1980 | 370 | 0.010 |
Why?
|
Oxygen Consumption | 2 | 1988 | 1869 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2005 | 1338 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2005 | 1116 | 0.010 |
Why?
|
Skin | 1 | 1991 | 4364 | 0.010 |
Why?
|
Magnesium | 1 | 1981 | 813 | 0.010 |
Why?
|
Erythrocytes | 1 | 2007 | 2455 | 0.010 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1997 | 118 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1809 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1997 | 441 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1997 | 349 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3920 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5892 | 0.010 |
Why?
|
Weight Loss | 1 | 2007 | 2622 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 12804 | 0.010 |
Why?
|
Biological Availability | 1 | 1996 | 397 | 0.010 |
Why?
|
Veins | 1 | 1979 | 770 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 1996 | 8037 | 0.010 |
Why?
|
Arteries | 1 | 1979 | 1119 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4751 | 0.010 |
Why?
|
Fetus | 1 | 2001 | 1880 | 0.010 |
Why?
|
Catheterization | 1 | 1978 | 1470 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1996 | 1032 | 0.010 |
Why?
|
Chronic Disease | 1 | 2007 | 9146 | 0.010 |
Why?
|
Gestational Age | 1 | 2001 | 3493 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1996 | 1950 | 0.010 |
Why?
|
Tendons | 1 | 1996 | 548 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2000 | 2969 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1997 | 2649 | 0.010 |
Why?
|
Point Mutation | 1 | 1996 | 1623 | 0.010 |
Why?
|
Genetic Markers | 1 | 1997 | 2634 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1978 | 1912 | 0.010 |
Why?
|
Acute Disease | 1 | 1980 | 7149 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2005 | 9438 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 1980 | 1537 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16689 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1986 | 7181 | 0.000 |
Why?
|
Neuronal Plasticity | 1 | 1996 | 1422 | 0.000 |
Why?
|
Recombinant Fusion Proteins | 1 | 1996 | 3772 | 0.000 |
Why?
|
Kidney | 1 | 2003 | 7186 | 0.000 |
Why?
|
Guideline Adherence | 1 | 1997 | 2266 | 0.000 |
Why?
|
Metoprolol | 1 | 1987 | 93 | 0.000 |
Why?
|
Hypertension | 1 | 1987 | 8480 | 0.000 |
Why?
|
Propanolamines | 1 | 1987 | 167 | 0.000 |
Why?
|
Enflurane | 1 | 1986 | 17 | 0.000 |
Why?
|
Phenylephrine | 1 | 1987 | 301 | 0.000 |
Why?
|
Memory | 1 | 1996 | 2174 | 0.000 |
Why?
|
Halothane | 1 | 1986 | 206 | 0.000 |
Why?
|
United States | 1 | 1993 | 69872 | 0.000 |
Why?
|
Propranolol | 1 | 1987 | 502 | 0.000 |
Why?
|
Nitrous Oxide | 1 | 1986 | 177 | 0.000 |
Why?
|
Base Sequence | 1 | 1996 | 12797 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1996 | 13815 | 0.000 |
Why?
|
Phenotype | 1 | 2001 | 16365 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 18111 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 72290 | 0.000 |
Why?
|
Mutation | 1 | 2005 | 29786 | 0.000 |
Why?
|
Osmolar Concentration | 1 | 1980 | 683 | 0.000 |
Why?
|
Pressure | 1 | 1982 | 1203 | 0.000 |
Why?
|
Surgery, Plastic | 1 | 1984 | 624 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1985 | 77449 | 0.000 |
Why?
|
Sodium | 1 | 1980 | 1623 | 0.000 |
Why?
|
Electrocardiography | 1 | 1986 | 6442 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1982 | 12026 | 0.000 |
Why?
|